Mirabegron (Betmiga®)
Symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome
Rapid Review
| Commenced | Completed | Outcome |
| 19/12/2012 |
12/03/2013 |
Full Pharmacoeconomic Assessment Not Recommended |